49 results on '"Michalski, J"'
Search Results
2. Survival Outcomes in Elderly Patients with Muscle Invasive Bladder Cancer: A Population Based Analysis
3. Stereotactic MR-Guided Adaptive Radiotherapy (SMART) for Ultra-Central Thorax Lesions: Results of a Phase 1 Trial
4. Effect of PTV and Collimator Margins on Tumor Control for Patients with Stage III Non-small Cell Lung Cancer in NRG Oncology RTOG-0617
5. Magnetic Resonance Image Guided Radiation Therapy (MR-IGRT) for the Treatment of Prostate Cancer: Initial Clinical Experience and Patient Selection
6. Prostate Cancer–Specific Mortality and Survival Outcomes for Salvage Radiation Therapy After Radical Prostatectomy
7. Initial Report of NRG Oncology/RTOG 0232: A Phase 3 Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone for Selected Patients With Intermediate-Risk Prostatic Carcinoma
8. Strategies to Improve Diet Quality Among Children With Autism Spectrum Disorders (ASDs): A Qualitative Study
9. Suboptimal Treatment Planning Adds Substantial Risk of Normal Tissue Complication: A Secondary Study on RTOG 0126
10. Cost-Effectiveness Analysis of Proton Versus Photon Therapy With Respect to Risk of Growth Hormone Deficiency
11. Initial Evaluation of the First Commercially Available Knowledge-Based Planning Software
12. Comparative Effectiveness Analysis of Patient-Reported Quality of Life (QOL) After Stereotactic Body Radiation Therapy as Compared to Intensity Modulated Radiation Therapy or Low-Dose-Rate Brachytherapy up to 2 Years After Treatment
13. Defining Long Term Failure Risk in Patients With an Undetectable PSA After Salvage Radiation
14. Feasibility of Online Adaptive Planning Using an Onboard Magnetic-Resonance Image Guided Radiation Therapy (MR-IGRT) System
15. Early Quality of Life (QOL) Declines Correlate With Later QOL After Intensity Modulated Radiation Therapy, Low-Dose-Rate Brachytherapy, or Stereotactic Radiation for Prostate Cancer
16. Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer
17. Predictors of Radiotherapy-Related GI Toxicity from Anal Cancer DP-IMRT: Secondary Analysis of RTOG 0529
18. Practice-Based Evidence to Evidence-Based Practice: Initial Challenges in Building the NROR
19. Risk of Biochemical Failure in Patients With High-Risk Prostate Cancer Treated Definitively or Postoperatively With Intensity Modulated Radiation Therapy
20. Radium-223 Dichloride (Ra-223) Impact on Skeletal-Related Events, External Beam Radiation Therapy (EBRT), and Pain in Patients With Castration-Resistant Prostate Cancer (CRPC) With Bone Metastases: Updated Results From the Phase 3 ALSYMPCA Trial
21. Cost-Effectiveness of Proton Therapy Compared to Photon Therapy in the Management of Pediatric Medulloblastoma
22. Serum Testosterone Levels in Men Treated With Intensity Modulated Radiation Therapy for Prostate Cancer
23. No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy (SBRT) Among Medically Inoperable Patients With Early Stage Peripheral Non-small Cell Lung Cancer: An Analysis of RTOG 0236
24. A Multi-Institutional Evaluation of Electronic Incident Reports: Anticipating a National Reporting System
25. Analysis Of Brachytherapy Plans For Regulatory Compliance: Application Of Expected Doses To Organs At Risk
26. Multi-institutional Prospective Evaluation of Bowel Quality of Life after Prostate External Beam Radiation Therapy Identifies Patient and Treatment Factors Associated with Patient Reported Outcomes
27. Dynamic Jaws and Dynamic Couch Tomotherapy for High Risk Prostate Cancer
28. Comparison of Motion Induced Dose Decrement between Prone and Supine Prostate Radiotherapy
29. Feasibility of Fiducial-based Electromagnetic Tracking for Postoperative Radiotherapy to the Prostate Bed
30. Radiation Therapy Oncology Group (RTOG) Consensus Panel Atlas of Musculoskeletal Anatomy (CAMAS) for Soft Tissue Sarcoma of the Extremities
31. A Practical Method of Adaptive Radiotherapy for Prostate Cancer using Real-time Electromagnetic Tracking
32. Stereotactic Body Radiation Therapy for Medically Inoperable Early-stage Lung Cancer Patients: Analysis of RTOG 0236
33. A Feasibility Study and Optimization of Dosimetric Objective with Heterogeneity Corrections for RTOG Studies with Hypo-fractionated Stereotactic Radiotherapy of Lung Cancers
34. Pelvic Intensity Modulated Radiation Therapy for High Risk Prostate Cancer
35. Preliminary Analysis of RTOG 9902: Increased Toxicity Observed with the Use of Adjuvant Chemotherapy
36. Health-Related Quality of Life and Cognitive Status in Patients with Glioblastoma Multiforme Receiving Escalating Doses of Conformal Three-Dimensional Radiation on RTOG 9803
37. Neoadjuvant Hormone Therapy (NHT) Leads to Immediate Impairment of Vitality/Hormonal and Sexual Quality of Life: Results of a Multi-Center Prospective Study
38. Outcome for Clinical Group III Rhabdomyosarcoma Patients Who Did Not Receive Radiotherapy on IRS-III and -IV
39. Predicting outcome after PSA failure in prostate cancer patients treated by radiation. Who needs salvage therapy
40. Phase I/II conformal three-dimensional radiation therapy dose escalation study in patients with supratentorial glioblastoma multiforme: Report of the radiation therapy oncology group 98–03 protocol
41. Year of treatment as an independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era
42. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995
43. Toxicity following 3D radiation therapy for prostate cancer on RTOG 9406 dose level V
44. The effect on toxicity of induction hormonal therapy in prostate cancer patients receiving dose escalated 3D conformal radiation therapy on RTOG 94-06
45. Preliminary report of toxicity following 3D Conformal Radiation Therapy (3DCRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy)
46. Local/regional failure in patients with rhabdomyosarcoma (rms) and microscopic residual disease
47. Mean dose of radiation to the bulb of the penis correlates with risk of impotence at 24 months: Preliminary analysis of Radiation Therapy Oncology Group (RTOG) phase I/II dose escalation trial 9406
48. Excretion of cobalamin and haptocorrin in the meconium of cystic fibrosis, premature, and control neonates
49. The efficacy and safety of Kytril ® tablets (2MG) once daily in patients receiving at least 10 fractions of upper abdominal radiation for malignancy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.